Is the US prepared to deal with another pandemic or widespread health crisis?

This is a genuinely contested question, with experts offering notably mixed assessments. The picture is complicated — the U.S. retains some strong technical capabilities, but many public health officials and watchdog groups warn that recent policy and funding changes have significantly weakened readiness.

Reasons for concern

Federal funding and workforce cuts. Throughout 2025–2026, HHS has undergone major restructuring. According to a Trust for America's Health (TFAH) analysis, health departments in states and localities nationwide are facing severe budget reductions due to current and proposed federal cuts, funding clawbacks, layoffs and hiring freezes, and agency reorganizations. The administration's FY2026 budget proposal would cut CDC funding substantially — the President's proposed FY 2026 budget for CDC amounts to a 53 percent reduction in funding as compared to FY 2024, reflecting cuts to CDC and its sister agency, the Agency for Toxic Substances and Disease Registry. Within that, CDC's Public Health Emergency Preparedness program faces a 52 percent funding reduction.

TFAH's 2026 "Ready or Not" report, released as the organization marked its 25th anniversary, found that the country faced the most severe flu season in nearly a decade, rising measles outbreaks, continued H5N1 avian influenza activity, and a growing number of extreme weather events—all while federal systems built over decades to help states prepare for emergencies came under significant strain. The report also warns that national preparedness depends not only on state capacity, but also on strong and stable federal health and preparedness systems, sustained intergovernmental coordination, and long-term investment in public health infrastructure.

State-level readiness is also uneven — the report places 20 states in the high-performance tier, 17 states and the District of Columbia in the middle-performance tier, and 13 states in the low-performance tier.

Leadership and institutional gaps. The White House's dedicated pandemic office has been hollowed out: in 2025, Gerald Parker resigned as head of the Office of Pandemic Preparedness and Response Policy, leaving the office with no employees.

Retreat from global health cooperation. The U.S. has pulled back from international coordination mechanisms. In 2025, the administration dismantled USAID, and in 2026, the U.S. announced its withdrawal from the WHO after almost 78 years of membership. A global pandemic-preparedness assessment noted that the withdrawal of the United States from WHO introduces a structural discontinuity in surveillance and financing that no complementary arrangement yet remedies.

GAO findings on coordination. A government audit found persistent structural problems: coordinating HHS's preparedness programs could allow it to better manage them and support jurisdictions preparing public health and health care systems, since lessons from COVID-19 demonstrated the importance of coordination between state health departments and hospitals for effective preparedness.

Reasons for cautious optimism

Core biodefense infrastructure remains funded. Despite cuts elsewhere, key countermeasure programs persist. ASPR's FY2026 operating plan shows continued investment in BARDA, the Strategic National Stockpile, Project BioShield, and a dedicated "Disease X" medical countermeasure program, alongside funding for regional special-pathogen treatment centers and hospital preparedness cooperative agreements.

Demonstrated response capability. When a real-world test emerged, the system mobilized. A 2026 Ebola outbreak response encompassed the Pentagon, CDC, USAID, the Department of Homeland Security, state officials, hospitals, foreign governments and aid groups overseas, prompting the U.S. to deploy military assets, build treatment centers, and organize airport screening.

Administration rhetoric emphasizes early detection. The administration's 2025 "America First Global Health Strategy" included stated goals of enabling early detection and containment of outbreaks, though outside analysts have been skeptical this offsets broader cuts.

Bottom line

The honest answer is: it's mixed and contested, with many experts expressing significant worry. The U.S. still has substantial scientific, pharmaceutical, and emergency-response infrastructure (BARDA, the Strategic National Stockpile, hospital networks, and demonstrated surge capacity). However, public health organizations, GAO auditors, and former officials are warning that simultaneous federal workforce reductions, proposed CDC budget cuts exceeding 40-50%, the dismantling of the White House pandemic office, and withdrawal from WHO and USAID-related global surveillance networks have eroded the coordination and early-warning systems that worked best during COVID-19. Whether the U.S. is "prepared" likely depends heavily on the type of crisis (a slow-moving one may allow time to reconstitute capacity; a fast-moving, high-lethality pathogen would stress-test exactly the systems that have been most destabilized) and on which specific states or regions are affected, given the wide preparedness gap TFAH identified between states.